Acquisition

JNJ
Biotech

J&J pays $3B cash for Halda's cancer cell death tech

At the center of the acquisition is Halda’s “hold and kill” bifunctional small molecule platform and a lead candidate in prostate cancer.
Angus Liu Nov 17, 2025 10:19am
money bag of money cash sack of money

Novo CEO tells Pfizer to 'bid higher' if it wants to win Metsera

Nov 7, 2025 10:00am
DPHARM 2025

Publisher’s note: Questex acquires The Conference Forum, Versalinx

Nov 4, 2025 12:00pm
graphic of a larger shark chomping up a smaller one

Cardiometabolic field drives M&A while cancer deals drop: report

Oct 27, 2025 2:39pm
Illustration connected puzzle pieces with the acronym MA

Ipsen inks €1B buyout of French biotech ImCheck

Oct 22, 2025 10:33am
The abstract concept of teamwork partnership merger alliance

Concentra strikes again, circling up IGM Biosciences

Jul 1, 2025 9:58am